Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Template:Current week ecosystem agenda"

From Bioblast
Line 1: Line 1:
{{Template:Science for Ukraine}}
{{Template:Science for Ukraine}}
2022 Week 38
  2022 Week 39


*'''Sep-19 Mo'''  
*'''Sep-26 Mo'''
:{|
:::: '''»[[EMC2022 Prague CZ]]«''' Sep 22-26
| width="100" align="center" | [[Image:MitoGlobal.jpg|45px|link=https://www.mitoglobal.org/index.php/MitoGlobal_Events|MitoGlobal Events]]
----
| '''World Mitochondrial Disease Week''' Sep 18-24<br>
World Mitochondrial Disease Week raises awareness of mitochondrial disease through educational, fundraising and advocacy activities.<br>
See what is happening near you - »https://mitochondrialdiseaseweek.org/events/
|}


*'''Sep-27 Tu'''
:::: '''»[[EMBO-FEBS Lecture Course 2022 Budva ME]]«''' Sep 27-Oct 1
----
----


*'''Sep-20 Tu'''
*'''Sep-28 We'''
 
:::: '''»[[BMT 2022 Innsbruck AT]]«''' Sep 28-30
:{|
| width="100" align="center" |[[File:2022.4.jpg|100px|link=https://doi.org/10.26124/bec:2022-0004 |Åsander Frostner 2022 BEC]]
|'''Bioenerg Commun 2022.4: A review on the current landscape of mitochondrial disease drug development'''<br>
*Åsander Frostner E, Simón Serrano S, Chamkha I, Donnelly E, Elmér E, Hansson MJ (2022) Towards a treatment for mitochondrial disease: current compounds in clinical development. https://doi.org/10.26124/bec:2022-0004
:from the O2k-Network »[[SE Lund Elmer E]]«
|}
----
----


*'''Sep-21 We'''  
*'''Sep-29 Th'''
:::: '''»[[The 77th Japanese Society of Physical Fitness and Sports Medicine 2022 Tochigi JP]]«''' Sep 21-23
:{|
 
| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
|''' "By tracing the carbon flow of the nutrients glucose and glutamine in cells derived from patients with different genetically defined causes of primary mitochondrial diseases (PMD), we identified several key metabolic changes supporting the major importance of an NAD<sup>+</sup>/NADH imbalance in PMD." '''<br>
*Adant I, Bird M, Decru B, Windmolders P, Wallays M, de Witte P, Rymen D, Witters P, Vermeersch P, Cassiman D, Ghesquière B (2022) Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction. [[Adant 2022 Mol Metab|»Bioblast link«]]
:from the O2k-Network »[[BE Leuven Vermeersch P]]«
 
|}


----
----


*'''Sep-22 Th'''
*'''Sep-30 Fr'''
:::: '''»[[MiPNet27.06 BEC tutorial-Living_Communications pmF |BEC tutorial-Living_Communications ''pmF'']]«''' Prague, Sep 22
:::: '''»[[MiPNet27.05_BEC_tutorial-Living_Communications_pmF |BEC tutorial-Living_Communications ''pmF'']]«''' Schröcken, Sep 30 - Oct 2
:::: '''»[[EMC2022 Prague CZ]]«''' Sep 22-26
:{|
| width="100" align="center" | [[File:O2k-brief.png|45px|link=http://wiki.oroboros.at/index.php/O2k-brief|O2k-brief repository]]
|''' A ketogenic diet is a promising approach towards alleviating mitochondrial dysfunction in MELAS disease.''' <br>
* Belal S, Goudenège D, Bocca C, Dumont F, Chao De La Barca JM, Desquiret-Dumas V, Gueguen N, Geffroy G, Benyahia R, Kane S, Khiati S, Bris C, Aranyi T, Stockholm D, Inisan A, Renaud A, Barth M, Simard G, Reynier P, Letournel F, Lenaers G, Bonneau D, Chevrollier A, Procaccio V (2022) Glutamate-induced deregulation of krebs cycle in mitochondrial encephalopathy lactic acidosis syndrome stroke-like episodes (MELAS) syndrome is alleviated by ketone body exposure. [[Belal 2022 Biomedicines|»Bioblast link«]]<br>


:from the O2k-Network »[[FR Angers Gueguen N]]«
:::: Abstract submission deadline for »[[AlgaEurope 2022 Rome IT]]«
|}
----


*'''Sep-23 Fr'''
:::: Abstract submission deadline for »[[AussieMit 2022 Sydney AU]]«
:{|
| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
|'''Investigating the cause of late-onset ''SLC25A26''-related mitochondrial disease'''<br>
*      Schober FA, Tang JX, Sergeant K, Moedas MF, Zierz CM, Moore D, Smith C, Lewis D, Guha N, Hopton S, Falkous G, Lam A, Pyle A, Poulton J, Gorman GS, Taylor RW, Freyer C, Wredenberg A (2022) Pathogenic SLC25A26 variants impair SAH transport activity causing mitochondrial disease.  [[Schober 2022 Hum Mol Genet|»Bioblast link«]]
:from the O2k-Network »[[BE Leuven Vermeersch P]]«


|}
:::: Abstract submission deadline for »[[CRUK Beatson Institute Workshop 2022 Glasgow UK]]«
----
----
*'''Sep-24 Sa'''


----
*'''Oct-01 Sa'''
*'''Sep-25 Su'''


::::-» '''12:10 (GMT+2): [[Gnaiger Erich|Erich Gnaiger]] presenting at [[EMC2022 Prague CZ]]''' - ''[[Gnaiger 2020 PaduaMuscleDays |Body mass excess, muscle mass, obesity and mitochondrial fitness]]''<br>
:::: Abstract submission deadline for »[[BPS2023 San Diego US]]«
 
----

Revision as of 08:27, 26 September 2022

Gentle Science
Oroboros declares solidarity against the Russian aggression-war in Ukraine and against all aggression-wars worldwide. -  »More details
A future for Ukraine is the future of its science
 2022 Week 39 
  • Sep-26 Mo
»EMC2022 Prague CZ« Sep 22-26

  • Sep-27 Tu
»EMBO-FEBS Lecture Course 2022 Budva ME« Sep 27-Oct 1

  • Sep-28 We
»BMT 2022 Innsbruck AT« Sep 28-30

  • Sep-29 Th

  • Sep-30 Fr
»BEC tutorial-Living_Communications pmF« Schröcken, Sep 30 - Oct 2
Abstract submission deadline for »AlgaEurope 2022 Rome IT«
Abstract submission deadline for »AussieMit 2022 Sydney AU«
Abstract submission deadline for »CRUK Beatson Institute Workshop 2022 Glasgow UK«

  • Oct-01 Sa
Abstract submission deadline for »BPS2023 San Diego US«